Serum calcification propensity is associated with HbA1c in type 2 diabetes mellitus
Open Access
- 1 January 2021
- journal article
- research article
- Published by BMJ in BMJ Open Diabetes Research & Care
- Vol. 9 (1), e002016
- https://doi.org/10.1136/bmjdrc-2020-002016
Abstract
Introduction Serum calcification propensity is emerging as an independent predictor for cardiovascular outcomes in high-risk populations. Calcification propensity can be monitored by the maturation time of calciprotein particles in serum (T-50 test). A low T-50 value is an independent determinant of cardiovascular morbidity and mortality in various populations. Aim was to investigate the T-50 and its relationship to type 2 diabetes mellitus. Research design and methods Using nephelometry, serum T-50 was cross-sectionally measured in 932 stable patients with type 2 diabetes mellitus (55% male) with a median age of 66 (62-75) years, diabetes duration of 6.5 (3.0-10.2) years and hemoglobin A1c (HbA1c) of 49 (44-54) mmol/mol. Results Serum T-50 was normally distributed with a mean value of 261 +/- 66 min. In linear regression, serum T-50 was lower in women and current smokers. A lower T-50 value was found in patients with a higher HbA1c or higher systolic blood pressure, insulin users and patients with a longer history of diabetes. The association with HbA1c was independent of other determinants in multivariable analysis. There was no association between T-50 and previous macrovascular events or the presence of microvascular disease. Conclusions Serum calcification propensity is independently associated with glycemic control, suggesting that a lower HbA1c may be associated with better cardiovascular outcomes. Retrospective analysis could not establish an association between a history of macrovascular events and T-50, and prospective studies will have to be performed to address this hypothesis.This publication has 26 references indexed in Scilit:
- Patients with diabetes differ in atherosclerotic plaque characteristics and have worse clinical outcome after iliofemoral endarterectomy compared with patients without diabetesJournal of Vascular Surgery, 2016
- Clinical Update: Cardiovascular Disease in Diabetes MellitusCirculation, 2016
- Calcification of vascular smooth muscle cells is induced by secondary calciprotein particles and enhanced by tumor necrosis factor-αAtherosclerosis, 2016
- Nanoparticle-Based Test Measures Overall Propensity for Calcification in SerumJournal of the American Society of Nephrology, 2012
- Fetuin-Mineral Complex Reflects Extraosseous Calcification Stress in CKDJournal of the American Society of Nephrology, 2010
- Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failureKidney International, 2009
- Structural Basis of Calcification Inhibition by α2-HS Glycoprotein/Fetuin-APublished by Elsevier BV ,2003
- Diabetes and AtherosclerosisJama-Journal Of The American Medical Association, 2002
- Differential Expression of Bone Matrix Regulatory Proteins in Human Atherosclerotic PlaquesArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- High expression of genes for calcification-regulating proteins in human atherosclerotic plaques.JCI Insight, 1994